Commencement of a new obesity drug trial
An announcement has been made by Perlecan Pharma Private Limited, an integrated drug development company about the commencement of phase I clinical trials of its new generation pan-PPAR activator drug c DRL 11605 in Canada. Read More...

Majority of the U.S. adults don't prefer exercise
Majority of the U.S. adults do not take part in any form of physical exercise. Though it's a known fact that a minimum amount of daily exercise is recommended for avoiding the occurrence of severe ailments like obesity and other chronic diseases. Read More...